Shoreham Associates provided the following information from its current year trial balance. Shoreham Associates Trial Balance (Partial) For the Year Ended December 31, 2022 Debit Credit $ 78,000 725,000 195,000 $ 125 375,000 866 4,000 890 200 Common Stock (no par) Beginning Balance Retained Earnings. Beginning Balance Accumulated Other Comprehensive Income - Beginning Balance Dividends Sales Dividend Income Interest Income Gain on Disposal of Plant Assets Unrealized Gain on Trading Securities Cost of Goods Sold Selling Expenses Advertising Expense Office Salaries Expense Sales Salaries Expense Office Supplies Expense Accounting and Legal Fees - Administrative Systems Consulting Fees - Administrative Amortization Expense - Administrative Depreciation Expense - Administrative Interest Expense - Administrative Unrealized Loss on Available For Sale Investments. Before Tax Loss on Asset Impairment Loss on Discontinued Operations - Before Tax 50,000 5.000 7,250 6,700 2,100 2.000 300 350 5,500 8,650 900 1.200 467 1,500 Additional information is provided below: 389 54,000 14,500 Income Tax Rate Issued Common Stock on 10/1/2022 Repurchase of Shoreham Stock 12/31/2022 Prepare the following: A) Multi-step Income Statement B) Separate statement of Comprehensive Income C) Statement of Stockholders Equity